Literature DB >> 28083755

High Risk of Readmission in Octogenarians Undergoing Primary Hip Arthroplasty.

Arthur L Malkani1, Brian Dilworth2, Kevin Ong3, Doruk Baykal4, Edmund Lau4, Theresa N Mackin5, Gwo-Chin Lee5.   

Abstract

BACKGROUND: As life expectancy increases, more elderly patients with end-stage hip arthritis are electing to undergo primary THA. Octogenarians undergoing THA have more comorbidities than younger patients, but this is not reflected in risk adjustment models for bundled care programs. The burden of care associated with THA in octogenarians has not been well characterized, and doing so may help these value-based programs make adjustments so that this vulnerable patient population does not risk losing access under accountable care models. QUESTIONS/PURPOSES: The purpose of this study was to describe care use, comorbidities, and complications among octogenarians undergoing primary THA.
METHODS: Five percent of the Medicare national administrative claims data was queried to identify patients diagnosed with hip osteoarthritis between January 1, 1998, and December 31, 2013. Patients who underwent primary THA were identified and followed longitudinally during the study period using their unique, encrypted Medicare beneficiary identifiers. We compared risk factors and complications between the octogenarian group versus those aged 65 to 69 years. Multivariate Cox regression was used to evaluate the effect of patient/hospital factors on risk of revision, periprosthetic joint infection, dislocation, venous thromboembolism (VTE), and mortality. Patient factors in the model included age, sex, race, region, socioeconomic status, and health status based on Charlson comorbidity score 12 months before replacement surgery.
RESULTS: There were 11,960 THAs in the octogenarians in 1998, which increased to 21,620 in 2013, an 81% increase during this study period. Octogenarians were more likely to have a Charlson score of 3 or higher than those patients aged 65 to 69 years (30% versus 17%, odds ratio [OR] 2.07 [1.98-2.20]; p < 0.001), and they were more likely to have coronary artery disease or congestive heart failure (47% versus 29%, OR 2.16 [2.06-2.26]; p < 0.001). The octogenarian group had a greater risk of dislocation (+12%, p = 0.01), VTE (+14%, p < 0.001), and mortality (+150%, p < 0.001) compared with the younger age cohort. A total of 21% of the octogenarians were readmitted after surgery compared with 12% for patients in the younger group (OR=1.64, 95% confidence interval 1.54-1.75; p < 0.001).
CONCLUSIONS: Because octogenarians are at increased risk of dislocation, VTE, medical complications, and mortality after THA, value-based care models that penalize hospitals for readmissions and complications may inadvertently result in loss of access to care for this group of patients as a result of the financial makeup of these bundled care models. Value-based care models were developed to improve care and decrease healthcare costs but may have unintended consequences in the octogenarian with higher complication and readmission risks. Financial losses may lead to institutions from withdrawing from the Bundled Payments for Care Improvement program. To try to prevent this from happening to this vulnerable patient population, bundled care programs should evolve and be modified to allow for risk stratification in the overall payment formula to account for increased age and comorbid conditions to ensure continued successful participation in the program among all the stakeholders. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2017        PMID: 28083755      PMCID: PMC5670046          DOI: 10.1007/s11999-017-5241-9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  20 in total

Review 1.  Minimizing perioperative adverse events in the elderly.

Authors:  F Jin; F Chung
Journal:  Br J Anaesth       Date:  2001-10       Impact factor: 9.166

2.  Arthroplasty in the octogenarian: quantifying the risks.

Authors:  Hans J Kreder; Gregory K Berry; Ian A McMurtry; Stephen I Halman
Journal:  J Arthroplasty       Date:  2005-04       Impact factor: 4.757

3.  Revision total hip arthroplasty in patients 80 years or older.

Authors:  Anne Lübbeke; Constantinos Roussos; Christophe Barea; Werner Köhnlein; Pierre Hoffmeyer
Journal:  J Arthroplasty       Date:  2012-03-14       Impact factor: 4.757

4.  Primary total hip replacement in patients over 80 years of age.

Authors:  D P Newington; G C Bannister; M Fordyce
Journal:  J Bone Joint Surg Br       Date:  1990-05

5.  Cementless Tapered Femoral Stems for Total Hip Arthroplasty in Octogenarians.

Authors:  Stephanie A Riley; James R Spears; Langan S Smith; Michael A Mont; Randa K Elmallah; Jeffrey J Cherian; Arthur L Malkani
Journal:  J Arthroplasty       Date:  2016-05-12       Impact factor: 4.757

6.  Risks and benefits of elective hip replacement in the octogenarian.

Authors:  T W Phillips; R W Grainger; H S Cameron; L Bruce
Journal:  CMAJ       Date:  1987-09-15       Impact factor: 8.262

7.  Comparative effectiveness of metal-on-metal and metal-on-polyethylene bearings in Medicare total hip arthroplasty patients.

Authors:  Kevin J Bozic; Edmund C Lau; Kevin L Ong; Thomas P Vail; Harry E Rubash; Daniel J Berry
Journal:  J Arthroplasty       Date:  2012-05-17       Impact factor: 4.757

8.  Age-related changes in the hemostatic system.

Authors:  R Abbate; D Prisco; C Rostagno; M Boddi; G F Gensini
Journal:  Int J Clin Lab Res       Date:  1993

9.  The effect of age on pain, function, and quality of life after total hip and knee arthroplasty.

Authors:  C A Jones; D C Voaklander; D W Johnston; M E Suarez-Almazor
Journal:  Arch Intern Med       Date:  2001-02-12

10.  Outcome and long-term results following total hip replacement in elderly patients.

Authors:  R N Levy; C M Levy; J Snyder; J Digiovanni
Journal:  Clin Orthop Relat Res       Date:  1995-07       Impact factor: 4.176

View more
  7 in total

Review 1.  Improving Quality and Decreasing Cost by Reducing Re-admissions in Patients Undergoing Total Joint Arthroplasty.

Authors:  Daniel S Sveom; Mary K Otteman; Kevin L Garvin
Journal:  Curr Rev Musculoskelet Med       Date:  2017-09

2.  Mortality and complication rates in nonagenarians and octogenarians undergoing total hip and knee arthroplasty: a systematic review and meta-analysis.

Authors:  Dimitrios Kitridis; Konstantinos Tsikopoulos; Panagiotis Givissis; Byron Chalidis
Journal:  Eur Geriatr Med       Date:  2022-01-24       Impact factor: 1.710

3.  Thirty-day morbidity and mortality following primary total elbow arthroplasty in octogenarians.

Authors:  Puneet Gupta; Theodore Quan; Joseph E Manzi; Zachary R Zimmer
Journal:  Shoulder Elbow       Date:  2022-02-01

4.  Evaluation of the rate of post-operative dislocation in patients with ipsilateral valgus knee deformity after primary total hip arthroplasty.

Authors:  Hao Li; Jin-Wei Xie; Zi-Chuan Ding; Ming-Cheng Yuan; Ya-Hao Lai; Zong-Ke Zhou
Journal:  Int Orthop       Date:  2022-03-20       Impact factor: 3.479

5.  Is there a difference in mobility and inpatient physical therapy need after primary total hip and knee arthroplasty? A decade-by-decade analysis from 60 to 99 years.

Authors:  Nana Sarpong; Friedrich Boettner; Fred Cushner; Ethan Krell; Ajay Premkumar; Alejandro Gonzalez Della Valle; Carola Hanreich
Journal:  Arch Orthop Trauma Surg       Date:  2022-10-18       Impact factor: 2.928

6.  What Are Risk Factors for Infection after Primary or Revision Total Joint Arthroplasty in Patients Older Than 80 Years?

Authors:  Nipun Sodhi; Hiba K Anis; Rushabh M Vakharia; Alexander J Acuña; Peter A Gold; Luke J Garbarino; Bilal M Mahmood; Nicholas R Arnold; Joseph O Ehiorobo; Eric L Grossman; Michael A Mont; Martin W Roche
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

7.  Preoperative High, as well as Low, Platelet Counts Correlate With Adverse Outcomes After Elective Total Hip Arthroplasty.

Authors:  Rohil Malpani; Patawut Bovonratwet; Michael G Clark; Taylor D Ottesen; Michael R Mercier; Jonathan N Grauer
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.